Industry News
Premier makes a cautious ASX debut
Premier Bionics made a quiet entry to a cautious biotech market today when it listed on the Australian Stock Exchange. [ + ]
New study of testosterone deficiency
A collaboration between men's health specialists and pathologists aims to create a precision reference kit to diagnose testosterone deficiency in men. [ + ]
Intelligent Island sets priorities
A head-hunting expedition to find 30 to 40 research staff will be among the first priorities for Tasmania's recently-announced $40 million bioinformatics centre of excellence. [ + ]
Monsanto, Aventis to bid for GM canola production
Monsanto has confirmed that it is getting ready to file its submission for commercial production of its GM Roundup Ready canola variety to the Office of the Gene Technology Regulator (OGTR). [ + ]
States flex their muscles over GM-free zones
The rights of the states to designate agricultural zones in which genetically modified crops can be either banned or permitted has been reinforced by the body overseeing the national regulatory framework for gene technology. [ + ]
Bionomics broadens Genmab collaboration
Bionomics has added a third target to its antibody development collaboration with Danish biotech Genmab, broadening the project's product potential. [ + ]
International partnership to focus on Asia Pacific health
The UK-based Wellcome Trust has joined several Australian and New Zealand bodies in launching a major new program focusing on health problems of developing countries in South East Asia and the Pacific.
[ + ]Norwood gains US patent
Transdermal drug delivery company Norwood Abbey has gained US patent approval of a laser technology for internal drug delivery. [ + ]
Draft stem cell laws now out for consultation
National legislation on the use of embryonic stem cells in research is on track to be introduced to Parliament next month. [ + ]
Mimotopes and Baker combine on cardio treatment
A letter of intent to jointly develop a new class of drugs for the treatment of congestive heart failure and other cardiovascular diseases has been signed by combinatorial and medicinal chemistry company Mimotopes and the Baker Medical Research Institute. [ + ]
Cellestis teams up to test TB
Diagnostics developer Cellestis has entered a collaboration to test and distribute a tuberculosis diagnostic designed specifically for the Japanese market. [ + ]
Share price increase follows Biotron's HIV success
Canberra biotech Biotron has announced that its lead anti-HIV compound, BIT009 has shown inhibition of HIV-1 replication in infected human cells. [ + ]
New members for Anadis' advisory panel
One local and one international scientist have joined the ranks of natural biopharmaceutical developer Anadis. [ + ]
$20 million Tasmania bio-informatics centre
A $20 million Centre of Excellence in bio-informatics has been created for Tasmania under the Federal Government's $40 million Intelligent Island program.
[ + ]Portland Orthopaedics expands
Medical device company Portland Orthopaedics has expanded into a larger Sydney-based facility to develop and manufacture its new style of hip and knee replacement joints. [ + ]
